A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine

BACKGROUND: Protection against human respiratory syncytial virus (RSV) remains an unmet need potentially addressable by maternal immunization. This phase 1/2 study evaluated a bivalent prefusion F vaccine (RSVpreF) with antigens from RSV subgroups A and B. METHODS: Adults 18–49 years old (N = 618) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Edward E, Falsey, Ann R, Scott, Daniel A, Gurtman, Alejandra, Zareba, Agnieszka M, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Swanson, Kena A, Radley, David, Gomme, Emily, Cooper, David, Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016447/
https://www.ncbi.nlm.nih.gov/pubmed/34932102
http://dx.doi.org/10.1093/infdis/jiab612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016447/
https://www.ncbi.nlm.nih.gov/pubmed/34932102
http://dx.doi.org/10.1093/infdis/jiab612

Ejemplares similares